Faeth Therapeutics, Inc. (FTH) vs Geron Corporation (GERN)

A side-by-side comparison of Faeth Therapeutics, Inc. and Geron Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FTH vs GERN

growth of $100 · dividends reinvested · last 6y
FTH -92.8% (-35.5%/yr)GERN -36.3% (-7.2%/yr)GERN compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$7$64
FTH GERN

FTH vs GERN: by the numbers

  • •GERN is the larger company ($776M vs $693M market cap).
  • •Both run net losses; FTH's is the smaller (0.00% vs -34.17% net margin).

Metrics side by side

Valuation

MetricFTHGERN
P/S ratioN/A3.79
P/B ratio4.013.55

Profitability

MetricFTHGERN
Gross margin0.00%97.42%
Operating margin0.00%-29.28%
Net margin0.00%-34.17%
ROE-113.05%-31.97%
ROIC-110.62%-8.34%

Growth (annualized)

MetricFTHGERN
Revenue CAGR (5Y)N/A247.85%
Total return CAGR (5Y)-31.75%-1.87%

Frequently asked

How have FTH and GERN total returns compared?
Over the past 5 years, FTH delivered -31.75% and GERN delivered -1.87% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.